S. Jebors et al. / Tetrahedron 69 (2013) 7670e7674
7673
0.89 and 0.65 cc gꢁ1 was observed, respectively for OMS 10a and
10b, indicating the removal of Boc protecting groups, confirmed by
a positive Kaiser test.35 After treatment of cationic polyester 10 by
DCM/Et3N (9/1 v/v), a decrease of specific area and pore volume
(100 MHz, DMSO-d6): 173.7, 171.9, 168.9, 158.5, 156.4, 155.8, 144.1,
141.1, 138.0, 129.5, 128.7, 128.1, 127.5, 126.9, 125.7, 120.6, 79.2, 66.2,
64.9, 58.1, 55.9, 53.9, 52.7, 46.9, 42.5, 36.8, 32.5, 30.3, 28.6, 24.0,
22.9, 18.7, 7.7. 29Si NMR (75 MHz, DMSO-d6): ꢁ45.1. LC/MS m/z
949.4 [MþH]þ; HPLC tr, 2.04 min; m/z 847.3 Siliconium ions [dep-
sipeptide-Si(OH)2]þ; HPLC rt, 1.64 min. HRMS (ESI) m/z calcd for
C42H55O11N6Si [M]þ 847.3698, found 847.3704.
(281 and 157 m2 ꢁ1; 0.74 and 0.44 cc gꢁ1) was observed despite
g
chain length contraction, due to the increase of volume oligomer
and decrease of hydrophilicity, a negative Kaiser test confirming
the disappearance of free amino groups.
In conclusion, we showed that OMS hybrid materials of SBA-15
type, functionalized with COOH groups could be used as nano-
reactors for controlled Ring Opening oligopolymerization of lactone
units. The obtained switchable oligomers confined in the pores
were fully accessible and the polyester to polyamide trans-
formation was quantitative. These tailored oligomers could be used
as switchable nanovalves in multifunctionalized nanobiomaterials
for drug delivery control for instance.
3.3. Preparation of hybrid depsipeptideeOMS by grafting 3
To a solution of SBA-15 (500 mg) in 20 mL of dry DMF was added
hybriddepsipeptideblock2(50mg). Thereactionmixturewasstirred
for1 hatroom temperatureand 24 hat80ꢀC. ThefunctionalizedSBA-
15 (SBA-Pep) wasfiltered off andwashed with DMF (3ꢂ10 mL),1DCM
(3ꢂ10 mL), diethylether (3ꢂ10 mL), and dried in vacuo.
The deprotection step was realized by treatment of the hybrid
silica with 5 mL TFA/DCM (2/1 v/v) for 1 h. The functionalized
deprotected SBA-15 (SBA-Pep) was filtered off and washed with
DMF (3ꢂ10 mL), DCM (3ꢂ10 mL), diethylether (3ꢂ10 mL), and dried
in vacuo.
3. Experimental section
3.1. Synthesis of depsipeptide 1
Fmoc-Lys-NH2 (4 equiv) was anchored on a trityl chloride resin
using DIEA (8 equiv) and anhydrous DMF. The reaction mixture was
stirred at room temperature for 2 h, and then washed with DMF/
MeOH/DIEA (17/2/1) (3ꢂ), DCM (3ꢂ), MeOH (1ꢂ), DCM (1ꢂ).
3.4. Synthesis of carboxylic functionalized mesoporous silica
7 at 0.7 mmol gL1
Quantitative Fmoc tests were performed as spot checks. The N
a
-
4.0 g of triblock copolymer [EO20PO70EO20 with PEO [poly(-
ethylene oxide)] and PPO [poly(propylene oxide)], and Pluronic
P123 as surfactant were dissolved in an aqueous HCl solution
(160 mL, pH¼1.5). This solution was poured into a mixture of TEOS
(8.86 g, 42.6 mmol) and 0.5 g (2.2 mmol) of cyanopropyltriethox-
ysilane at room temperature. The mixture was stirred for 2 h giving
rise to a microemulsion. After heating this perfectly transparent
solution at 60 ꢀC, a small amount of NaF (80 mg) was added under
stirring to induce polycondensation. The mixture was left at 60 ꢀC
under stirring for 48 h. The resulting solid was filtered and washed
with ethanol and ether. The surfactant was removed by hot ethanol
extraction in a Soxhlet apparatus for 24 h. After filtration and
drying at 60 ꢀC in vacuo, 3.10 g (95%) of the nitrile functionalized
OMS 6 were obtained as a white solid. 500 mg of nitrile function-
alized OMS was converted into carboxylic acid OMS 7 by treatment
with 5 mL of H2O/H2SO4 solution (1/1 v/v), stirred at 150 ꢀC for 5 h,
filtered, and washed with water and acetone, and dried in vacuo.
Fmoc deprotection step was performed by treatment with a solu-
tion of piperidine (20% v/v in DMF) for 20 min.
Boc-Ser-OH elongation was performed using the Fmoc/tBu
strategy using BOP as coupling reagent. The coupling step was
carried out on the resin using Boc-Ser-OH (3 equiv) in DMF in the
presence of BOP (3 equiv) and DIEA (6 equiv) for 2 h at room
temperature. After the coupling step, the resin was washed with
DMF (3ꢂ), DCM (3ꢂ), MeOH (1ꢂ), and DCM (1ꢂ).
DIC (3 equiv) and DMAP (0.3 equiv) were added to a solution of
Fmoc-Phe-OH (6 equiv relative to the resin substitution) in a mix-
ture of anhydrous DCM and DMF (50/50) at 0 ꢀC (3 mL mmolꢁ1).
The resulting mixture was stirred with the previously functional-
ized resin for 6 h at room temperature. This procedure was re-
peated twice, and resin was washed with DMF (3ꢂ), DCM (3ꢂ),
MeOH (1ꢂ), and DCM (1ꢂ).
Solid-supported depsipeptides were cleaved by stirring the
resin with a TFE/AcOH/DCM (2/1/7 v/v/v) solution for 1 h. After
filtration, the resin was submitted to a second cleavage step for an
additional 1 h and filtered. The combined filtrates were concen-
trated under reduced pressure. The depsipeptide 1 was precipitated
with diethylether, filtered, and dried under high vacuum. Crude
compounds were analyzed by analytical HPLC and LC/MS and used
without further purification. LC/MS m/z 702.3 [MþH]þ; HPLC tr,
1.55 min. HRMS (ESI) m/z calcd for C38H48O8N5 [MþH]þ 702.3503,
found 702.3497.
3.5. Preparation of serine lactone
To a stirred solution of dried Ph3P (4.9 mmol) in 100 mL of an-
hydrous THF at ꢁ80 ꢀC was added DEAD (4.9 mmol) dropwise over
10 min. After 15 min, a solution of Boc-L-Serine (4.88 mmol) in THF
was added dropwise over 15 min to the stirred solution at ꢁ80 ꢀC.
The solution was stirred at ꢁ80 ꢀC for 20 min and overnight at room
temperature. Solvent was removed in vacuo, and the resulting
product was purified by chromatography on silica gel using EtOAc/
Hexane (30/70 v/v) as eluent.
3.2. Synthesis of hybrid of triethoxysilyl depsipeptide 2
To a solution of depsipeptide (1) (0.1 mmol) in 100 mL of DMF
was added DIEA (2.1 equiv) and 3-isocyanatopropyltriethoxysilane
(1.2 equiv). The reaction mixture was stirred for 2 h at room tem-
perature. Reaction was monitored by HPLC. Ether (30 mL) was
poured into the reaction mixture. The precipitate was suspended in
ether and collected by filtration. This procedure was repeated three
times to remove TICPS and DIEA. All crude compounds were ana-
lyzed by analytical HPLC, LC/MS, and NMR and used without further
purification. 1H NMR (400 MHz, DMSO-d6): 0.47 (m, 2H), 1.14 (t, 9H,
J¼7.2 Hz), 1.23 (m, 2H), 1.37 (m, 6H), 2.88e2.97 (m, 6H), 3.69e3.76
(q, 6H, J¼7.2 Hz, J¼14), 4.06e4.40 (m, 8H), 5.68e5.78 (m, 2H), 7.06
(s, 2H), 7.10 (s, 2H), 7.15e7.64 (m, 13H), 7.88 (br s, 3H). 13C NMR
3.6. Lactone oligomerisation (exp 1, 2)
500 mg of carboxylic acid mesoporous silica 7 was poured into
a solution of potassium pentadionate (1.2 equiv) in 5 mL of anhy-
drous ethanol. The suspension was refluxed for 24 h, filtered,
washed with ethanol, and dried to give the respective potassium
carboxylate salt. 200 mg of this material were poured into a solu-
tion of dibenzo-18-crown-6 ether in dichloromethane placed in
a 12 mL plastic syringe equipped with frit. A solution of serine
lactone was added to the syringe, placed overnight under gentle
stirring. Syringe was percolated and functionalized OMS was